Catastrophizing makes pain more painful, makes it last longer, and makes pain much harder to treat.
The NASEM report, which was commissioned by the FDA, gives an update on current research in the pain field.
Older adults with chronic pain have been found to have poorer memory and executive function than their younger counterparts.
An FDA panel previously voted that the drug's benefits no longer outweigh its risks.
Reports of pain may indicate a preclinical course of amyotrophic lateral sclerosis.
The VA and DoD issue a clinical practice guideline regarding opioid therapy for chronic pain in veterans.
Clinically and statistically significant reductions in peripheral neuropathy were seen following neurofeedback.
Spinal cord stimulation using precision approach via 3D neural targeting shows superior efficacy in treating chronic axial low back pain compared with a trial-and-error method to achieve desired paresthesia.
The recommendations promote the use of hot compresses and physical therapy as first-line treatment of low back pain.
New research suggests that opioid addiction may be linked to a genetic variant, and more personalized treatment may help those with the change.
Interventions with clinical massage or guided imagery may help ease pain and anxiety in patients in a progressive care unit.
Neurology Advisor Articles
- Minocycline May Slow Progression From Clinically Isolated Syndrome to Multiple Sclerosis
- Brain Inflammation Observed in Obsessive-Compulsive Disorder
- Extended-Release Amantadine Reduces Levodopa-Induced Dyskinesia in Parkinson's Disease
- Growing Old Without Alzheimer's Pathology: What's the Secret?
- Traumatic Brain Injury May Increase Later Risk of Dementia